Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT01252251
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2010-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-01
First Submit QC Date:
None
Study First Post Date:
2010-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-15
Results First Submit QC Date:
None
Results First Post Date:
2017-08-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-06
Last Update Post Date:
2017-08-01
Last Update Post Date Type:
ACTUAL